|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.84 CAD | -1.18% |
|
+2.44% | +1.20% |
| Jan. 29 | Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023 | CI |
| 2023 | Cannara Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
Cannara Biotech Inc. reported earnings results for the first quarter ended November 30, 2022. For the first quarter, the company reported sales was CAD 0.867912 million compared to CAD 0.899004 million a year ago. Revenue was CAD 10.31 million compared to CAD 6.56 million a year ago.
Net income was CAD 0.002951 million compared to net loss of CAD 0.530499 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.20% | 55.24M | |
| +31.96% | 272M | |
| +33.74% | 261M | |
| +49.42% | 194M | |
| +44.98% | 131M | |
| -28.57% | 121M | |
| +115.91% | 119M | |
| -42.17% | 119M | |
| 0.00% | 86.82M | |
| +150.00% | 75.33M |
CANNARA BIOTECH INC. 
